Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230291 · ClinicalTrials.gov registry record · NA
Hidradenitis Suppurativa Written Action Plan
A NA study, sponsored by University of Arizona.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04230291: Clinical Trial NA study, sponsored by University of Arizona.
NCT04230291 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04230291, a NA study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.
Primary Outcome
Number of visits to ER, urgent care, or hospitalizations because of HS
Interventions
- BEHAVIORAL Verbal consultation
- BEHAVIORAL Written Action Plan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2020-03-17 |
| Phase | NA |
Why NCT04230291 stopped before completion
NCT04230291 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Verbal consultation is the first listed.
NCT04230291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04230291 about?
NCT04230291 is a clinical study titled "Hidradenitis Suppurativa Written Action Plan". This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.
What is the current status of trial NCT04230291?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2020-02-01. Estimated completion is 2020-03-17.
What interventions are being tested in trial NCT04230291?
The interventions under investigation include: Verbal consultation (BEHAVIORAL), Written Action Plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT04230291?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04230291's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI